Skip to content

Fund+

Active Risk: not assessed
Public limited companyfounded 201511 yrs activeGroot Begijnhof 60, 3000 Leuven, BelgiumKBO/BCE: BE 0629.896.521
Summary

Fund+ is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €124.01M and a net result of €-1.77M. Equity is growing by ~2.8% per year across the filed fiscal years. Its solvency ranks better than 95% of 5527 sector peers (fiscal year 2025). The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals.

Watch
Print / PDF

Checked score

Outside the general model
Model not applicable to financial institutions
The health score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term

Signals

1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-06-2026, 52 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
52 d early
2024
45 d early
2023
33 d early
2022
40 d early
2021
53 d early
2020
38 d early
2019
37 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€124.01M▲ 2.3%
2024 · €121.27M
2018: €89.08M 2019: €105.13M 2020: €47.28M 2021: €123.87M 2022: €119.59M 2023: €118.99M 2024: €121.27M
2018 → 2025
Net result
€-1.77M
2024 · €2.29M
2018: €1.08M 2019: €16.05M 2020: €497k 2021: €21.42M 2022: €-4.28M 2023: €17.18M 2024: €2.29M
2018 → 2025
Total assets
€124.10M▲ 0.9%
2024 · €123.01M
2018: €90.59M 2019: €105.56M 2020: €105.68M 2021: €129.59M 2022: €119.84M 2023: €143.53M 2024: €123.01M
2018 → 2025
Solvency
99.9%▲ 1.3pp
2024 · 98.6%
2018: 98.3% 2019: 99.6% 2020: 44.7% 2021: 95.6% 2022: 99.8% 2023: 82.9% 2024: 98.6%
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Turnover€2k
Equity€123.87M-€119.59M▼ 3.5%€118.99M▼ 0.5%€121.27M▲ 1.9%€124.01M▲ 2.3%
Operating result€-2.65M-€-2.64M▲ 0.2%€-2.97M▼ 12.4%€-2.13M▲ 28.4%€-1.58M▲ 25.9%
Net result€21.42M-€-4.28M€17.18M€2.29M▼ 86.7%€-1.77M
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€-10.00M€0€10.00M€20.00MOperating result 2021: €-2.65M€-2.65MNet result 2021: €21.42M€21.42MOperating result 2022: €-2.64M€-2.64MNet result 2022: €-4.28M€-4.28MOperating result 2023: €-2.97M€-2.97MNet result 2023: €17.18M€17.18MOperating result 2024: €-2.13M€-2.13MNet result 2024: €2.29M€2.29MOperating result 2025: €-1.58M€-1.58MNet result 2025: €-1.77M€-1.77M20212022202320242025€-10M€0€10M€20MOperating result 2023: €-2.97M€-3MNet result 2023: €17.18M€17MOperating result 2024: €-2.13M€-2.1MNet result 2024: €2.29M€2.3MOperating result 2025: €-1.58M€-1.6MNet result 2025: €-1.77M€-1.8M202320242025
The operating result stays negative: a loss of €1.58M in 2025 against €2.13M in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €124.10M
Fixed assets €109.53M ▲ 21.4%
Current assets €14.57M ▼ 55.6%
Equity and liabilities €124.10M
Equity €124.01M ▲ 2.3%
Debt €99k ▼ 94.3%
Debt's share of the balance-sheet total falls from 1.4% to 0.1%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
ROE
-1.4%▼
2024 · 1.9%
ROA
-1.4%▼
2024 · 1.9%
Debt ≤ 1 year
€44k▼
2024 · €1.71M
Debt > 1 year
€0
Income taxes
€-6k▼
2024 · €-159
Staff costs
€260k▲
2024 · €194k
A ratio outside any meaningful range has been withheld (balance sheet total €124.10M, equity €124.01M).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 60 lines
Balance sheet Code20242025
Assets
Total assets20/58€123.01M€124.10M▲
Fixed assets21/28€90.22M€109.53M▲
Tangible fixed assets22/27€8k€6k▼
Furniture and vehicles24€8k€6k▼
Financial fixed assets28€90.21M€109.53M▲
Current assets29/58€32.79M€14.57M▼
Amounts receivable within one year40/41€7k€136k▲
Trade receivables40€2k-
Other amounts receivable41€6k€136k▲
Current investments50/53€24.45M€10.28M▼
Cash at bank and in hand54/58€8.26M€4.16M▼
Deferred charges and accrued income490/1€74k-
Equity and liabilities
Total equity and liabilities10/49€123.01M€124.10M▲
Equity10/15€121.27M€124.01M▲
Contributions10/11€102.44M€106.94M▲
Capital10€101.24M€105.74M▲
Issued capital100€101.24M€105.74M▲
Outside capital11€1.20M€1.20M=
Share premium1100/10€1.20M€1.20M=
Revaluation surpluses12-€0
Reserves13€5.57M€5.57M=
Non-distributable reserves130/1€5.57M€5.57M=
Legal reserve130€5.57M€5.57M=
Profit (loss) carried forward14€13.26M€11.49M▼
Investment grants15-€0
Advance to shareholders on the distribution of net assets19-€0
Amounts payable17/49€1.74M€99k▼
Amounts payable after more than one year17-€0
Amounts payable within one year42/48€1.71M€44k▼
Current portion of amounts payable after more than one year42-€0
Financial debts43-€0
Trade debts44€295k€20k▼
Suppliers440/4€295k€20k▼
Taxes, remuneration and social security45€20k€24k▲
Remuneration and social security454/9€20k€24k▲
Other amounts payable47/48€1.39M-
Accrued charges and deferred income492/3€27k€55k▲
Income statement Code20242025
Turnover70€2k-
Goods, raw materials, services and sundry goods60/61€1.93M€1.31M▼
Remuneration, social security and pensions62€194k€260k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€3k▼
Other operating charges640/8€394€7▼
Non-recurring operating charges66A€3k€2k▼
Gross operating margin9900€-1.93M€-1.31M▲
Operating profit (loss)9901€-2.13M€-1.58M▲
Financial income75/76B€21.32M€814k▼
Recurring financial income75€853k€814k▼
Non-recurring financial income76B€20.47M-
Financial charges65/66B€16.90M€1.01M▼
Recurring financial charges65€835k€1.01M▲
Non-recurring financial charges66B€16.07M-
Profit (loss) for the period before taxes9903€2.29M€-1.77M▼
Income taxes67/77€-159€-6k▼
Profit (loss) for the period9904€2.29M€-1.77M▼
Profit (loss) for the period to be appropriated9905€2.29M€-1.77M▼
Appropriation of the result
Profit (loss) to be appropriated9906€13.38M€11.49M▼
Profit (loss) brought forward from the previous period14P€11.09M€13.26M▲
Transfer to equity691/2€114k-
To the legal reserve6920€114k-
Social balance
Average headcount (FTE)90871.01.0=

The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
09-06
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
22-01
State Gazette act Resignation: FONTAINE François (director)
Appointment: FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ (director) · Permanent representative: FONTAINE François · Capital increase9 facts ▸
  • General meeting, 19-12-2025
  • Director resignation, FONTAINE François (director)
  • Director appointment, FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ (director)
  • Permanent representative, FONTAINE François
  • Capital increase, €4.499.000
  • Bank account, 18-12-2025
  • Capital, €105.737.717,5
  • Statutes amendment
  • Power of attorney, DE LEEUW Bart
2025
31-12
Financial Liquidity times 17current ratio 332.53
Current ratio from 19.19 to 332.53; short-term debt falls from €1.71M to €44k.
16-06
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial Liquidity times 12current ratio 19.19
Current ratio from 1.61 to 19.19; short-term debt falls from €24.54M to €1.71M.
26-08
State Gazette act Resignation: Pienter-Jan BV (director)
Appointment: Chris Buyse (director)3 facts ▸
  • Board meeting, 25-06-2024
  • Director resignation, Pienter-Jan BV (director)
  • Director appointment, Chris Buyse (director)
28-06
State Gazette act Resignations & appointments
Resignations: Multifin SA, Compass CommV and 3 others · Permanent representatives: Gérard Lamarche, Luc Debruyne and 3 others · Appointments: LGP Advisory BV (director) and Luc Debruyne (director)22 facts ▸
  • General meeting, 03-06-2024
  • Director resignation, Multifin SA (director)
  • Permanent representative, Gérard Lamarche
  • Director resignation, Compass CommV (director)
  • Permanent representative, Luc Debruyne
  • Director resignation, Pienter-Jan BV (director)
  • Permanent representative, Chris Buyse
  • Director resignation, V.M.F. NV (director)
  • Permanent representative, Urbanus Vandeurzen
  • Director resignation, François Fontaine (director)
  • Director appointment, LGP Advisory BV (director)
  • Permanent representative, Kenneth Bonheure
  • +10 further facts in this act
28-06
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial Back to profitnet €17.18M
Net result €17.18M after one loss-making year.
08-11
State Gazette act Resignations: Mark Waer (director) and Debasish Roychowdhury (director)
Appointment: Luc Debruyne (chair of the board) · Permanent representative: Chris Buyse · Power of attorney8 facts ▸
  • Board meeting, 20-06-2023
  • Director resignation, Mark Waer (director)
  • Director appointment, Luc Debruyne (chair of the board)
  • Board meeting, 27-06-2023
  • Director resignation, Debasish Roychowdhury (director)
  • Power of attorney, Bart De Leeuw
  • Permanent representative, Chris Buyse
  • Power of attorney, Junomati BV
21-06
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
12-06
State Gazette act Reappointment: BDO Bedrijfsrevisoren BV (statutory auditor)
Permanent representative: Beert Kegels3 facts ▸
  • General meeting, 07-06-2022
  • Auditor reappointment, BDO Bedrijfsrevisoren BV
  • Permanent representative, Beert Kegels
Show earlier events
2022
31-12
Financial Weakest financial yearnet €-4.28M ▼120%
Net result drops to €-4.28M, the lowest in the series; recovery starts the following year.
31-12
Financial Liquidity times 8current ratio 62.31
Current ratio from 8.21 to 62.31; short-term debt falls from €5.72M to €245k.
08-06
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial Highest result since 2018net €21.42M ▲4211%
Net result €21.42M, the highest in the series.
31-12
Financial Liquidity times 15current ratio 8.21
Current ratio from 0.56 to 8.21; short-term debt falls from €58.40M to €5.72M.
31-12
Financial Equity above €100MEq €123.87M ▲162%
4 profitable years in a row build equity to €123.87M.
23-06
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
16-07
State Gazette act Resignations: PIENTER-JAN BV, Francois FONTAINE and 5 others
Appointments: Mutifin BV (director) and COMPASS CommV (director) · Permanent representatives: Gerard LAMARCHE, Luc DEBRUYNE and 2 others · Reappointments: PIENTER-JAN BV, Francois FONTAINE and 2 others19 facts ▸
  • General meeting, 01-06-2020
  • Director resignation, PIENTER-JAN BV (director)
  • Director resignation, Francois FONTAINE (director)
  • Director resignation, Dr. IR. U. Vandeurzen Management Firm BV (director)
  • Director resignation, Désiré COLLEN (director)
  • Director resignation, Arnoud DE PRET ROOSE DE CALESBERG (director)
  • Director resignation, Pierre DRION (director)
  • Director resignation, Dr. D. ROYCHOWDHURY (director)
  • Director appointment, Mutifin BV (director)
  • Permanent representative, Gerard LAMARCHE
  • Director appointment, COMPASS CommV (director)
  • Permanent representative, Luc DEBRUYNE
  • +7 further facts in this act
24-06
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
22-04
State Gazette act Resignation: Hilde Laga (bestuurster)
2 facts ▸
  • Board meeting, 10-12-2019
  • Director resignation, Hilde Laga (bestuurster)
2019
31-12
Financial Liquidity triplescurrent ratio 126.93
Current ratio from 39.13 to 126.93; short-term debt falls from €1.51M to €425k.
31-12
Financial Equity above €100MEq €105.13M ▲18%
2 profitable years in a row build equity to €105.13M.
08-08
State Gazette act Reappointment: BDO Bedrijfsrevisoren CVBA (statutory auditor)
Permanent representative: Bert Kegels · Mandate compensation4 facts ▸
  • General meeting, 03-06-2019
  • Auditor reappointment, BDO Bedrijfsrevisoren CVBA (statutory auditor)
  • Permanent representative, Bert Kegels
  • Mandate compensation, BDO Bedrijfsrevisoren CVBA
21-06
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
07-09
State Gazette act Appointment: Mark Waer (director)
Mandate compensation3 facts ▸
  • General meeting, 05-06-2018
  • Director appointment, Mark Waer (director)
  • Mandate compensation, Mark Waer
25-06
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
10-01
State Gazette act Capital & shares
Capital · Statutes amendment3 facts ▸
  • General meeting, 29-09-2017
  • Capital, €101.238.717,5
  • Statutes amendment
2017
31-10
State Gazette act Permanent representative: Bert Kegels
2 facts ▸
  • Board meeting
  • Permanent representative, Bert Kegels
12-10
State Gazette act Capital & shares · Statutes amendment
Statutes amendment · Approval · Capital decrease13 facts ▸
  • General meeting, 29-09-2017
  • Statutes amendment
  • Approval, 13-09-2017
  • Capital decrease, €36.940.522,5
  • Power of attorney, Fund+
  • Capital increase, €15.000.000
  • Capital increase, €8.268.000
  • Capital increase, €41.475.000
  • Capital increase, €14.007.900
  • Capital increase, €14.088.340
  • Statutes amendment
  • Capital, €31.667.477,5
  • +1 further facts in this act
02-08
State Gazette act Appointments: Debasish Roychowdhury (director) and François Fontaine (director)
2 facts ▸
  • Director appointment, Debasish Roychowdhury (director)
  • Director appointment, François Fontaine (director)
01-07
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
14-10
State Gazette act Capital & shares
Capital increase · Capital · Power of attorney7 facts ▸
  • General meeting, 27-09-2016
  • Capital increase, €12.300.000
  • Capital increase, €7.715.000
  • Capital, €45.340.000
  • Power of attorney, Raad van Bestuur
  • Power of attorney, Voorzitter
  • Power of attorney, Gedelegeerd Bestuurder
21-01
State Gazette act Appointment: LAGA Hilde Maria Joseph (independent director)
Capital increase · Capital4 facts ▸
  • General meeting, 30-12-2015
  • Capital increase, €2.500.000
  • Capital, €25.325.000
  • Director appointment, LAGA Hilde Maria Joseph (independent director)
2015
14-08
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment4 facts ▸
  • General meeting, 23-07-2015
  • Capital increase, €4.325.000
  • Capital, €22.825.000
  • Statutes amendment
02-06
State Gazette act Appointments: Dr. Ir. U. VANDEURZEN MANAGEMENT FIRM, DRION Pierre René Ghislain and DE PRET ROOSE DE CALESBERG Arnoud Alfred Marie Gaston Ghislain
Permanent representative: VANDEURZEN Urbanus (roepnaam Urbain) Agnes Lambert · Capital increase · Capital8 facts ▸
  • General meeting, 13-05-2015
  • Capital increase, €9.500.000
  • Capital, €18.500.000
  • Director appointment, Dr. Ir. U. VANDEURZEN MANAGEMENT FIRM (referentieaandeelhouder bestuurder)
  • Permanent representative, VANDEURZEN Urbanus (roepnaam Urbain) Agnes Lambert
  • Director appointment, DRION Pierre René Ghislain (independent director)
  • Director appointment, DE PRET ROOSE DE CALESBERG Arnoud Alfred Marie Gaston Ghislain (independent director)
  • Number of directors, 5
20-05
State Gazette act Incorporation
Appointments: COLLEN Désiré José Louis, PIENTER-JAN and BDO Bedrijfsrevisoren - BDO Réviseurs d'Entreprises · Permanent representative: BUYSE Chris Georges Frans · Founding capital11 facts ▸
  • Incorporation, 07-05-2015
  • Founding capital, €9.000.000
  • Founder, Désiré Collen Stichting
  • Founder, Life Sciences Research Partners
  • Director appointment, COLLEN Désiré José Louis (dcs bestuurder)
  • Director appointment, PIENTER-JAN (managing director)
  • Permanent representative, BUYSE Chris Georges Frans
  • Auditor appointment, BDO Bedrijfsrevisoren - BDO Réviseurs d'Entreprises
  • Authorised capital, 200000000, 5 jaar
  • Share issue, vergoeding inbreng in natura, 5000
  • Director appointment, COLLEN Désiré José Louis (chair of the board)
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
9 directors, no change since 2025
SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT
Director · since 04-09-2025 · Public limited company · perm. rep.: FONTAINE François
Current
Chris Buyse
Director · since 25-06-2024
Current
DR. IR. U. VANDEURZEN MANAGEMENT FIRM
Director · since 03-06-2024 · Public limited company · perm. rep.: VANDEURZEN Urbanus (roepnaam Urbain) Agnes Lambert
Current
FONTAINE François Gabriel
Director · since 03-06-2024
Current
LGP Advisory
Director · since 03-06-2024 · Private limited company · perm. rep.: Kenneth Bonheure
Current
Luc Debruyne
Director · since 08-11-2023
Current
3 other directors
Dr. D. ROYCHOWDHURY
Director · since 01-06-2020
Not recently confirmed
COLLEN Désiré José Louis
Dcs bestuurder · since 07-05-2015
Not recently confirmed
PIENTER-JAN
Managing director · since 07-05-2015 · Legal entity · perm. rep.: BUYSE Chris Georges Frans
Not recently confirmed
04-09-2025 SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT: Appointed as Director
04-09-2025 FONTAINE François: Resigned as Director
25-06-2024 Chris Buyse: Appointed as Director
03-06-2024 DR. IR. U. VANDEURZEN MANAGEMENT FIRM: Reappointed as Director
03-06-2024 FONTAINE François Gabriel: Reappointed as Director
Full history in the Timeline (29 changes) →
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 2015
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Groot Begijnhof 603000 Leuven
Ground area
1,571 m²
Building footprint
158 m²
Volume, LiDAR
1,482 m³
Parcel 24504D1049/00M000, Flanders · tallest building 13.3 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Fund+
Groot Begijnhof 60, 3000 LeuvenFinancial service activities, except insurance and pension funding
since 20152.244.735.693
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24504D1049/00M000
ProtectedMonumentGroot BegijnhofSource ↗
 Flanders 1,571 m² 1 · 158 m² 13.3 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).

Statutory auditor

1 auditor
BDO Bedrijfsrevisoren bvCurrent
Auditor · represented by Beert Kegels
07-06-2022 → present
Show 1 earlier auditors
BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES
Statutory auditor · represented by Bert Kegels
succeeded by BDO Bedrijfsrevisoren bv in 2022
08-05-2015 → 07-06-2022

Articles of association

Purpose
De Vennootschap heeft tot doel het functioneren als een beleggings- en investeringsvennootschap en daartoe de door haar aangetrokken middelen te beleggen, en dit voornamelijk maar…
Full purpose

De Vennootschap heeft tot doel het functioneren als een beleggings- en investeringsvennootschap en daartoe de door haar aangetrokken middelen te beleggen, en dit voornamelijk maar niet uitsluitend in ondernemingen en andere entiteiten die actief zijn in de wetenschappen die vallen onder de noemer life sciences (o.m. de biowetenschappen, de medische wetenschappen) en de wetenschappen in het algemeen, en alle daarmee gerelateerde technologieën, ontwikkelingen en toepassingen.

according to the deed of 20-05-2015

Structure & network

Connections & network

76 connected companies
Chris Buyse, Shared director, links 10 companies CBChris BuyseFondation Francqui, via Chris Buyse FFFondationFrancquiBioSenic, via Chris Buyse BBioSenicCatalent Gosselies, via Chris Buyse CGCatalentGosseliesCATALENT GOSSELIES HOLDING, via Chris Buyse CGCATALENTGOSSELIES…Celyad Oncology, via Chris Buyse COCelyadOncologyFluvius System Operator, via Chris Buyse FSFluvius SystemOperatoriTeos Belgium, via Chris Buyse IBiTeos BelgiumPIENTER-JAN, via Chris Buyse PPIENTER-JANSOFIA, via Chris Buyse SSOFIAVLAAMSE ENERGIEHOLDING, via Chris Buyse VEVLAAMSEENERGIEHOLDINGLuc Debruyne, Shared director, links 3 companies LDLuc DebruyneZ.org KU Leuven, via Luc Debruyne ZKZ.org KULeuvenGlaxoSmithKline Biologicals, via Luc Debruyne GBGlaxoSmithKlineBiologicalsFund+ Fund+0629.896.521
Shared directors
Linked via shared directors
→
Z.org KU Leuven
via Luc Debruyne · Bestuurder en lid van de algemene vergadering
→
BioSenic
via Chris Buyse · Director
former→
former→
Show 72 more companies with a shared director
former→
former→
Fluvius System Operator
via Chris Buyse · Member of day-to-day management
former→
former→
former→
iTeos Belgium
via Chris Buyse · Director
former→
PIENTER-JAN
via Chris Buyse · Permanent representative
former→
SOFIA
via Chris Buyse · Permanent representative
former→
former→
AEDIFICA
Shared director
→
Agfa-Gevaert
Shared director
→
Alumni Lovanienses
Shared director
→
ASSOCIATIE KU Leuven
Shared director
→
AXA BELGIUM
Shared director
→
BARCO
Shared director
→
BIO.BE
Shared director
→
Deloitte Legal-Lawyers
Shared director
→
ELIA ASSET
Shared director
→
Elia Group
Shared director
→
FINANCES ET INDUSTRIES
Shared director
→
FLUXYS
Shared director
→
FONDATION ULB
Shared director
→
Gimv
Shared director
→
ING BELGIQUE
Shared director
→
Oxurion
Shared director
→
PATCOBEL
Shared director
→
→
VLERICK RESEARCH
Shared director
→
ALDEA GROUP
Shared corporate director
→
Aphea.Bio
Shared corporate director
→
ASCO INDUSTRIES
Shared corporate director
→
Aviapartner Belgium
Shared corporate director
→
Banqup Group
Shared corporate director
→
Belgian Mobile ID
Shared corporate director
→
BeLightning
Shared corporate director
→
BIOXODES
Shared corporate director
→
CALYOS
Shared corporate director
→
CI SAIL 2025
Shared corporate director
→
CISSOID
Shared corporate director
→
COMET TRAITEMENTS
Shared corporate director
→
COMET TYRE RECYCLING
Shared corporate director
→
COMETSAMBRE
Shared corporate director
→
ELECTRAWINDS
Shared corporate director
→
EPICS THERAPEUTICS
Shared corporate director
→
EPIMEDE
Shared corporate director
→
HEX - RAYS
Shared corporate director
→
Inbiose
Shared corporate director
→
LINEAS
Shared corporate director
→
LINEAS GROUP
Shared corporate director
→
OncoDNA
Shared corporate director
→
Orizio
Shared corporate director
→
Palais des Congrès
Shared corporate director
→
Publiwind
Shared corporate director
→
Sabena Aerospace Engineering
Shared corporate director
→
SmartSec
Shared corporate director
→
Smile Invest
Shared corporate director
→
Smile Invest Management Company
Shared corporate director
→
SPARKI
Shared corporate director
→
THEODORUS IV
Shared corporate director
→
Triginta
Shared corporate director
→
Unibreda
Shared corporate director
→
VANBREDA RISK & BENEFITS
Shared corporate director
→
VIVES II - Louvain Technology Fund
Shared corporate director
→
ZEPHYR - FIN
Shared corporate director
→

Ownership & control

1 board mandate
Board mandates of this companythis company sits on their board1
Aelin Therapeutics
2 locations

Group per the LEI register

4 funds
4 funds in the register
Managed fund:American Beacon Cayman Trend Company, Ltd.
George Town, Cayman Islands
Managed fund:MassMutual Overseas Fund
Springfield, United States
Managed fund:NATIVE SAN & Company, L.L.C.
Huntsville, United States · LEI lapsed
Managed fund:THE GOODHAVEN FUNDS TRUST
Wilmington, United States · LEI lapsed

Capital and shareholders

Shareholders according to the acts
After 5 capital increases act of 12-10-2017 ↗
At incorporation act of 20-05-2015 ↗

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 22-01-2026 Capital increase of 4,499,000 EUR · to 105,737,717.50 EUR · 4,499 new shares · in cash
  2. 10-01-2018 Capital stated in the act · 101,238,717.50 EUR · 129,669 shares
  3. 12-10-2017 Capital reduction of 36,940,522.50 EUR · to 8,399,477.50 EUR · repaid to the shareholders
  4. 12-10-2017 Capital increase of 15,000,000 EUR · 15,000 new shares
  5. 12-10-2017 Capital increase of 8,268,000 EUR · 7,800 new shares
  6. 12-10-2017 Capital increase of 41,475,000 EUR · 41,475 new shares
  7. 12-10-2017 Capital increase of 14,007,900 EUR · 13,215 new shares
  8. 12-10-2017 Capital increase of 14,088,340 EUR · 6,839 new shares
Show 6 older capital entries
  1. 14-10-2016 Capital increase of 12,300,000 EUR · 12,300 new shares
  2. 14-10-2016 Capital increase of 7,715,000 EUR · 7,715 new shares
  3. 21-01-2016 Capital increase of 2,500,000 EUR · to 25,325,000 EUR · 2,500 new shares · in cash
  4. 14-08-2015 Capital increase of 4,325,000 EUR · to 22,825,000 EUR · 4,325 new shares · in cash
  5. 02-06-2015 Capital increase of 9,500,000 EUR · to 18,500,000 EUR · 9,500 new shares · in cash
  6. 20-05-2015 Incorporation · 9,000,000 EUR

Recognitions · licences · registrations

Legal Entity Identifier

967600DP3QW1O9VP6X78
live in the LEI register

Similar companies · same sector, comparable size

I4B - THE BELGIAN INFRASTRUCTURE FUND
BE 0721.470.261
Watermaal-Bosvoorde · Eq €133.88M
Maxus Fund
BE 0792.915.018
Nazareth · Eq €85.33M
UCB Ventures
BE 0667.816.096
Anderlecht · Eq €213.84M
EMV BEHEER
BE 0427.023.395
Oudsbergen · Eq €64.70M
QUAEROQ
BE 0862.330.988
Waregem · Eq €55.90M
Of 153 companies in sector 64310 we hold annual accounts for 73. 17 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded07-05-2015
Fiscal year end31-12
Activities, NACEBEL 2025
64310Financial service activities, except insurance and pension funding
Sources
Crossroads Bank for EnterprisesNational Bank · 10 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.

We would like to set cookies. That happens only with your consent. What we measure